Loading…
PMV Pharmaceuticals, Inc. is projected to rise to $1.49 by 2027, a +20% move from its current price of $1.24. PMVP is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $1.20 | $1.24 | $1.28 | -0.04% |
| Jul 15 | $1.19 | $1.24 | $1.29 | -0.07% |
| Jul 16 | $1.18 | $1.24 | $1.30 | -0.11% |
| Jul 17 | $1.17 | $1.24 | $1.31 | -0.14% |
| Jul 18 | $1.16 | $1.24 | $1.32 | -0.18% |
| Jul 19 | $1.15 | $1.24 | $1.33 | -0.21% |
| Jul 20 | $1.15 | $1.24 | $1.34 | -0.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.15 | $1.24 | $1.34 | -0.24% |
| Week 2 | $1.11 | $1.23 | $1.37 | -0.49% |
| Week 3 | $1.08 | $1.23 | $1.40 | -0.73% |
| Week 4 | $1.05 | $1.23 | $1.43 | -0.98% |
| Week 5 | $1.03 | $1.22 | $1.45 | -1.22% |
| Week 6 | $1.01 | $1.22 | $1.47 | -1.46% |
| Week 7 | $0.9961 | $1.22 | $1.49 | -1.70% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
PMV Pharmaceuticals, Inc. is a healthcare company focused on precision oncology. It engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States.
It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases.
The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
PMV Pharmaceuticals, Inc. (PMVP) is a healthcare stock with a current price of $1.21 and a market cap of $64.53M. It is ranked 4469 in market capitalization.
The 30-day price forecast is neutral in tone, with the average price projected to rise over time. In 2026, the forecast shows an average of $1.21, with higher potential in subsequent years as the model projects bullish momentum through 2050.
The year-by-year forecast delineates increasing maximum prices and growing returns, culminating in an average price of $7.48 by 2050 and a forecasted ROI of 518.2 for that year.
A major floor 25.8% below — a decisive break under it would weaken the trend.
The nearest floor, 15.3% below — buyers have tended to step in here.
The nearest ceiling, 8.1% above — a clean break opens room to run.
A major ceiling 32.3% above — clearing it would confirm fresh momentum.
Key PMVP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PMVP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.24 | Buy | $1.24 | Buy |
| MA 10 | $1.25 | Sell | $1.23 | Buy |
| MA 20 | $1.19 | Buy | $1.21 | Buy |
| MA 50 | $1.24 | Buy | $1.23 | Buy |
| MA 100 | $1.32 | Sell | $1.26 | Sell |
| MA 200 | $1.30 | Sell | $1.29 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.22 | Neutral |
| Stoch RSI (14) | 42.77 | Neutral |
| CCI (20) | 58.19 | Neutral |
| Williams %R (14) | -50.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 2.48 | Buy |
| Bollinger %B (20,2) | 0.69 | Neutral |
| Stochastic %K (14) | 50.00 | Neutral |
| TRIX (15) | -0.01 | Sell |
| Awesome (5,34) | 0.05 | Buy |
| Ultimate (7,14,28) | 38.28 | Neutral |
| Momentum (10) | 0.09 | Buy |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 1.24 | Buy |
| ADX (14) | 13.63 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is NEUTRAL. RSI14 is 50, indicating a balanced near-term momentum. The stock trades around the 50-day and 200-day moving averages, with SMA50 at $1.28 and SMA200 at $1.30. Support is marked at $1.05 and resistance at $1.42. The 30-day range runs from $1.01 to $1.45, and annualized volatility is 50%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.02 | $1.24 | $1.55 | 0% | Neutral | |
| $1.18 | $1.49 | $1.99 | +20% | Bullish | |
| $1.30 | $1.69 | $2.35 | +36% | Bullish | |
| $1.34 | $1.79 | $2.57 | +44% | Bullish | |
| $1.32 | $1.80 | $2.65 | +45% | Bullish | |
| $1.34 | $1.87 | $2.80 | +50% | Bullish | |
| $1.36 | $1.92 | $2.95 | +55% | Bullish | |
| $1.33 | $1.91 | $2.99 | +54% | Bullish | |
| $1.65 | $2.42 | $3.84 | +95% | Bullish | |
| $1.87 | $2.78 | $4.49 | +125% | Bullish | |
| $2.11 | $3.37 | $5.79 | +172% | Bullish | |
| $3.42 | $6.19 | $11.68 | +399% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.02 | $1.24 | $1.51 | +0.00% |
| August 2026 | $1.06 | $1.25 | $1.52 | +1.00% |
| September 2026 | $1.01 | $1.20 | $1.48 | -4.11% |
| October 2026 | $1.01 | $1.21 | $1.50 | +0.58% |
| November 2026 | $1.03 | $1.25 | $1.56 | +3.21% |
| December 2026 | $1.02 | $1.23 | $1.55 | -1.16% |
Click any year to see its month-by-month PMVP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The PMVP price prediction for 2026 points to an average of $1.24 (low $1.02, high $1.55) — a potential gain of 0% on today's $1.24. Price action looks broadly range-bound.
In 2027, PMVP is projected to trade between $1.18 and $1.99, averaging $1.49 — a potential gain of +20% from today's $1.24. That is up +20% on the projected 2026 average. Buyers look set to stay in control over this stretch.
PMV Pharmaceuticals, Inc.'s 2028 outlook centres on $1.69, within a $1.30 to $2.35 range. That is up +13% on the projected 2027 average. That marks a +36% change versus current levels. Momentum favours further upside here.
By 2029, PMVP could reach as high as $2.57, with a base case around $1.79 and support toward $1.34 — roughly +44% from $1.24. Buyers look set to stay in control over this stretch.
Expect PMVP to range from $1.32 to $2.65 through 2030. The $1.80 average target implies a +45% move from current prices. That is up +1% on the projected 2029 average. Momentum favours further upside here.
The PMVP price prediction for 2031 points to an average of $1.87 (low $1.34, high $2.80) — a potential gain of +50% on today's $1.24. Buyers look set to stay in control over this stretch.
In 2032, PMVP is projected to trade between $1.36 and $2.95, averaging $1.92 — a potential gain of +55% from today's $1.24. That is up +3% on the projected 2031 average. Momentum favours further upside here.
PMV Pharmaceuticals, Inc.'s 2033 outlook centres on $1.91, within a $1.33 to $2.99 range. That is -1% versus the projected 2032 average. That marks a +54% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, PMVP could reach as high as $3.84, with a base case around $2.42 and support toward $1.65 — roughly +95% from $1.24. Momentum favours further upside here.
Expect PMVP to range from $1.87 to $4.49 through 2035. The $2.78 average target implies a +125% move from current prices. That is up +15% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The PMVP price prediction for 2040 points to an average of $3.37 (low $2.11, high $5.79) — a potential gain of +172% on today's $1.24. Momentum favours further upside here.
In 2050, PMVP is projected to trade between $3.42 and $11.68, averaging $6.19 — a potential gain of +399% from today's $1.24. That is up +84% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in PMVP today (≈ 806.451613 PMVP) could be worth
$4,990.5
+$3,990.5 (+399%) by 2050 · US Dollar
Based on the average projected PMVP price of $6.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PMVPwould be worth at today's price.
$1,000 invested in PMVP on Jul 10, 2025 (≈ 787.401587 PMVP) would be worth
$976.38
-$23.62 (-2.4%) today · 0.98× · US Dollar
Based on a PMVP entry price of $1.27 vs. today's $1.24.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.22 | $1,016.39 | +1.6% |
| 1 month ago | $1.06 | $1,169.81 | +17.0% |
| 3 months ago | $1.32 | $939.39 | -6.1% |
| 6 months ago | $1.17 | $1,059.83 | +6.0% |
| 1 year ago | $1.27 | $976.38 | -2.4% |
| All time (5.0y) ago | $31.45 | $39.43 | -96.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PMVP forecast.
Our base-case forecast reaches $2.50 around 2035.
Implied market cap at $2.50: $133.33M
The multi-year forecast depicts a bullish trajectory across the horizon, with the average price rising from $1.21 in 2026 to $7.48 in 2050 and a long-run ROI of 518.2 for 2050. 2026 min $1.02, avg $1.21, max $1.54 with ROI 0; 2027 min $1.25, avg $1.57, max $2.10 with ROI 30.1; 2028 min $1.35, avg $1.74, max $2.41 with ROI 44.1; 2029 min $1.39, avg $1.84, max $2.61 with ROI 51.9; 2030 min $1.46, avg $1.97, max $2.87 with ROI 63; 2031 min $1.47, avg $2.02, max $3.00 with ROI 66.6; 2032 min $1.49, avg $2.08, max $3.15 with ROI 72.1; 2033 min $1.59, avg $2.26, max $3.48 with ROI 86.8; 2034 min $1.94, avg $2.80, max $4.39 with ROI 131.5; 2035 min $2.14, avg $3.14, max $4.99 with ROI 159.7; 2040 min $2.59, avg $4.06, max $6.86 with ROI 235.7; 2050 min $4.26, avg $7.48, max $13.82 with ROI 518.2.
These figures point to a rising average price path and substantial upside potential over the long term, but they are estimates and not guarantees. Investors should consider the underlying uncertainties and market conditions that could affect outcomes.
Tap a question to reveal the answer.
2030 min $1.46, avg $1.97, max $2.87; ROI 63; sentiment BULLISH.
The forecast shows a neutral start in 2026 (avg $1.21, ROI 0) with bullish momentum developing in 2027 (avg $1.57) and continuing through 2030 (avg $1.97; ROI 63). From 2031 onward, the outlook remains bullish with higher averages and rising ROIs (e.g., 2031 ROI 66.6, 2032 ROI 72.1).
Yes. The 2040 forecast max is $6.86, and the 2040 average is $4.06 with ROI 235.7. The 2034–2035 years also show larger price levels, culminating in higher potential by 2040.
Current price is $1.21 and market cap is $64.53M.
Sentiment is NEUTRAL. RSI14 is 50. SMA50 is $1.28 and SMA200 is $1.30. Support is $1.05 and resistance is $1.42. The 30-day range is $1.01 to $1.45, and annualized volatility is 50%.
PMV Pharmaceuticals, Inc. Community Discussion
0Share your PMV Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.